Are Differences in Filaggrin Expression Suitable for Discriminating Benign, Premalignant and Malignant Skin Lesions?
- 1 April 1989
- journal article
- research article
- Published by Elsevier in Pathology - Research and Practice
- Vol. 184 (4), 402-409
- https://doi.org/10.1016/s0344-0338(89)80035-4
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- β2 Microglobulin expression in keratoacanthomas and squamous cell carcinomaBritish Journal of Dermatology, 1987
- Characterization of Two Monoclonal Antibodies to Human Epidermal Keratohyalin: Reactivity With Filaggrin and Related ProteinsJournal of Investigative Dermatology, 1987
- Alterations in the Metabolism of Filaggrin in the Skin After Chemical- and Ultraviolet-Induced ErythemaJournal of Investigative Dermatology, 1986
- Filaggrin breakdown to water binding compounds during development of the rat stratum corneum is controlled by the water activity of the environmentDevelopmental Biology, 1986
- Cell surface carbohydrates in proliferative epidermal lesions.Journal of Cutaneous Pathology, 1986
- Keratoacanthoma and squamous cell carcinoma of the skin: Immunohistochemical localization of involucrin and keratin proteinsJournal of the American Academy of Dermatology, 1986
- Filaggrin: A Keratin Filament Associated ProteinaAnnals of the New York Academy of Sciences, 1985
- Involucrin in Squamous and Basal cell Carcinomas of the Skin: An Immunohistochemical StudyJournal of Investigative Dermatology, 1984
- Characterization of a class of cationic proteins that specifically interact with intermediate filaments.Proceedings of the National Academy of Sciences, 1981
- METASTASIZING KERATOACANTHOMAS? The Difficulties in Differentiating Keratoacanthomas from Squamous Cell CarcinomasPlastic and Reconstructive Surgery, 1978